Performance and thermoregulatory effects of chronic bupropion administration in the heat

European Journal of Applied Physiology

Volumn 105, Issue 3, 2009, Pages 493-498

  Roelands, Bart ^a   Hasegawa, Hiroshi ^a,d   Watson, Philip ^b   Piacentini, Maria Francesca ^a,c   Buyse, Luk ^a   Schutter, Guy ^a   Meeusen, Romain ^a  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b LOUGHBOROUGH UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF ROME FORO ITALICO   (Italy)

^d HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Central fatigue; Dopamine noradrenaline reuptake inhibition; Exercise; Thermoregulation

Indexed keywords

AMFEBUTAMONE; GROWTH HORMONE; NEUROTRANSMITTER; PLACEBO;

ADAPTATION; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORE TEMPERATURE; CROSSOVER PROCEDURE; CYCLING; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG RESPONSE; EXERCISE INTENSITY; GROWTH HORMONE BLOOD LEVEL; HEAT STRESS; HUMAN; HUMAN EXPERIMENT; MALE; MORNING DOSAGE; NEUROTRANSMISSION; NORMAL HUMAN; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THERMOREGULATION;

ADAPTATION, BIOLOGICAL; ADULT; BODY TEMPERATURE REGULATION; BUPROPION; DOPAMINE UPTAKE INHIBITORS; DRUG ADMINISTRATION SCHEDULE; EXERCISE; EXERCISE TEST; GROWTH HORMONE; HEART RATE; HOT TEMPERATURE; HUMANS; MALE; PHYSICAL ENDURANCE;

EID: 59249096471     PISSN: 14396319     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00421-008-0929-x     Document Type: Article

References (25)

1. Borg GA (1982) Psychophysical bases of perceived exertion. Med Sci Sports Exerc 14:377-381
2. Burgess ML, Davis JM, Borg TK, Buggy J (1991) Intracranial self-stimulation motivates treadmill running in rats. J Appl Physiol 71(4):1593-1597
3. Chekeley SE (1980) Neuroendocrine tests of monoamine function in man: A review of basic theory and its application to the study of depressive illness. Psychol Med 10:35-53
4. Committee for Proprietary Medicinal Products (2002) Bupropion hydrochloride, international non-proprietary name (INN): Bupropion. Euopean Agency for the Evaluation of Medicinal Products; CPMP/27610/02
5. George T, O'Malley S (2004) Current pharmacological treatments for nicotine dependence. Trends Pharmacol Sci 25:42-48. doi: 10.1016/ j.tips.2003.11.003
6. Hasegawa H, Meeusen R, Sarre S, Diltoer M, Piacentini MF, Michotte Y (2005) Acute dopamine/noradrenaline reuptake inhibition increases brain and core temperature in rats. J Appl Physiol 99(4):1397-1401. doi: 10.1152/japplphysiol.00435.2005
7. Hasegawa H, Piacentini MF, Sarre S, Michotte Y, Ishiwata T, Meeusen R (2008) Influence of brain catecholamines on the development of fatigue in exercising rats in the heat. J Physiol 586(1):141-149. doi: 10.1113/ jphysiol.2007.142190
8. Holm KJ, Spencer CM (2000) Bupropion: A review of its use in the management of smoking cessation. Drugs 59:1007-1024. doi: 10.2165/ 00003495-200059040-00019
9. Jefferson JW, Pradko JF, Muir KT (2005) Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations. Clin Ther 27(11):1685-1695. doi: 10.1016/j.clinthera.2005.11.011
10. Jeukendrup A, Saris WH, Brouns F, Kester AD (1996) A new validated endurance performance test. Med Sci Sports Exerc 28:266-270. doi: 10.1097/00005768-199602000-00017
11. Learned-Coughlin SM, Bergström M, Savitcheva I, Ascher J, Schmidt VD, Langstrom B (2003) In vivo activity of bupropion at the human dopamine transporter as measured by possitron emission tomography. Biol Psychiatry 54:800-805. doi: 10.1016/S0006-3223(02)01834-6
12. Liu YL, Connoley IP, Harrison J, Heal DJ, Stock MJ (2002) Comparison of the thermogenic and hypophagic effects of sibutramine's metabolite 2 and other monoamine reuptake inhibitors. Eur J Pharmacol 452:49-56. doi: 10.1016/S0014-2999(02)02226-4
13. Meeusen R, Watson P, Hasegawa H, Roelands B, Piacentini MF (2006) Central Fatigue: The serotonine hypothesis and beyond. Sports Med 36(10):881-909. doi: 10.2165/00007256-200636100-00006
14. Modell JG, Boyce S, Taylor E, Katholi C (2002) Treatment of atopic dermatitis and psoriasis vulgaris with bupropion SR: A pilot study. Psychosom Med 64:835-840. doi: 10.1097/01.PSY.0000021954.59258.9B
15. Nestler EJ, Hyman SE, Malenka RC (2001) Molecular neuropharmacology: A foundation for clinical neuroscience. McGraw-Hill, New York
16. Paterson NE, Balfour DJ, Markou A (2007) Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell. Eur J Neurosci 25(10):3099-3108. doi: 10.1111/j.1460-9568.2007.05546.x
17. Piacentini MF, Meeusen R, Buyse L, De Schutter G, Kempenaers F, Van Nijvel J, De Meirleir K (2002) No effect of a noradrenergic reuptake inhibitor on performance in trained cyclists. Med Sci Sports Exerc 34(7):1189-1193. doi: 10.1097/00005768-200207000-00021
18. Piacentini MF, Clinckers R, Meeusen R, Sarre S, Ebinger G, Michotte Y (2003) Effect of bupropion on hippocampal neurotransmitters and on peripheral hormonal concentrations in the rat. J Appl Physiol 95(2):652-656
19. Piacentini MF, Meeusen R, Buyse L, De Schutter G, De Meirleir K (2004) Hormonal responses during prolonged exercise are influenced by a selective DA/NA reuptake inhibitor. Br J Sports Med 38:129-133. doi: 10.1136/bjsm.2002.000760
20. Ramanathan LM (1964) A new weighting system for mean surface temperature of the human body. J Appl Physiol 19:531-532
21. Roelands B, Hasegawa H, Watson P, Buyse L, De Schutter G, Piacentini MF, Meeusen R (2008a) Acute DA reuptake inhibition enhances performance in warm but not temperate conditions. Med Sci Sports Exerc 40(5):858-879. doi: 10.1249/MSS.0b013e3181659c4d
22. Roelands B, Goekint M, Heyman E, Piacentini MF, Watson P, Hasegawa H, Buyse L, Pauwels F, De Schutter G, Meeusen R (2008b) Acute noradrenaline reuptake inhibition decreases performance in normal and high ambient temperature. J Appl Physiol 105:206-212. doi: 10.1152/ japplphysiol.90509.2008
23. Tella SR, Ladenheim B, Cadet JL (1997) Differential regulation of dopamine transporter after chronic self-administration of bupropion and nomifensine. J Pharmacol Exp Ther 281(1):508-513
24. Watson P, Hasegawa H, Roelands B, Piacentini MF, Loovrie R, Meeusen R (2005) Acute dopamine/noradrenaline reuptake inhibition enhances human exercise performance in warm, but not temperate conditions. J Physiol 565(3):873-883. doi: 10.1113/jphysiol.2004.079202
25. Yoshimura R, Yanagihara N, Hara K, Nakamura J, Toyohira Y, Ueno S, Izumi F (2001) Dual phases of functional change in norepinephrine transporter in cultured bovine adrenal medullary cells by long-term treatment with clozapine. J Neurochem 77:1018-1026. doi: 10.1046/ j.1471-4159.2001.00316.x